This work is licensed under a Creative Commons Attribution 4.0 International License.
(HHPHG)2
General Information
DCTPep ID DCTPep04793
Peptide Name (HHPHG)2
Sequence HHPHGHHPHG
Sequence Length 10
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Acetylation
Other Modification None
Chiral L
Physicochemical Information
Formula C50H64N22O11
Absent amino acids ACDEFIKLMNQRSTVWY
Theoretical pI 7.21
Acidic residues 0
Basic residues 6
Polar residues 2
Molecular weight (Average) 1149.2
Molecular weight (Monoisotopic) 1148.51
Common amino acids H
Net charge 6
Instability index (II) -17.5
Aliphatic index 0.00
Grand average of hydropathicity (GRAVY) -2.320
Half Life
3.5 hours (mammalian reticulocytes, in vitro).
10 min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 15313924
Title Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities
Doi 10.1158/0008-5472.CAN-04-0440
Year 2004
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
This work is licensed under a Creative Commons Attribution 4.0 International License.